Showing results (2141-2150 of 4,223) with videos related to
Sort By:
Pageof 423
Discover Oncology|August 25, 2025
Integrated single-cell and bulk RNA-sequencing data reveal prognosis and therapeutic response in low-grade glioma based on hypoxia-lactylation related genesHongyu Tang, Ruijie Zhang, Ying Xu, et al.Discover Oncology|August 25, 2025
Global research trends in PARP inhibitors for ovarian cancer: a bibliometric analysisXiaodong Wang, Gouping Ding, Jing He, et al.Discover Oncology|August 30, 2025
Systematic analysis identifies CDKN2A as a prognostic biomarker for hepatocellular carcinomaShilin He, Yanling Zhang, Junjie Xu, et al.Discover Oncology|September 1, 2025
Integrated pan-cancer and melanoma-specific analysis of angiopoietin-2: prognostic value, immune microenvironment modulation, and ceRNA network regulationXuejun Ni, Xiaofen Wan, Beichen Cai, et al.Discover Oncology|October 14, 2022
Tumor Treating Fields (TTFields) therapy vs physicians' choice standard-of-care treatment in patients with recurrent glioblastoma: a post-approval registry study (EF-19)Jay-Jiguang Zhu, Samuel A Goldlust, Lawrence R Kleinberg, et al.Discover Oncology|October 18, 2022
Prostate cancer induced bone pain: pathobiology, current treatments and pain responses from recent clinical trialsA E Smith, A Muralidharan, M T SmithDiscover Oncology|October 15, 2022
High expression of RUVBL1 and HNRNPU is associated with poor overall survival in stage I and II non-small cell lung cancer patientsJustyna Durślewicz, Jakub Jóźwicki, Anna Klimaszewska-Wiśniewska, et al.Discover Oncology|October 17, 2022
Validation of the CSRFENCE score for prediction of febrile neutropenia during chemotherapy cycles 2-6Razan Zatarah, Nour Faqeer, Aseel Mahmoud, et al.Discover Oncology|September 13, 2022
Reciprocal regulation of CIP2A and AR expression in prostate cancer cellsHao-Wen Chuang, Jian-Hua Pan, Yi-Xuan Cai, et al.Discover Oncology|January 21, 2025
Aging and tumors: a dynamic interactionYudi Zhang, Siqiang Zhu, Zhaodong Liu, et al.Pageof 423